Lil’ Drug Store Products now offers EZ OTC for convenience store retailers. There are 20 tablets in the convenience-sized package. The over-the-counter products can be sold for a suggested retail price of $3.99. EZ OTC has the value of private label from one vendor, and comes with one box size and one price point. The
FDA has posted a draft guidance to help persons submitting applications for new tobacco products understand the premarket tobacco product application process. The draft guidance addresses questions such as: • Who may submit a new tobacco product application • When to submit a new tobacco product application • What information the FD&C Act requires you
Kretek International Inc., U.S. distributor of ExtenZe, a male enhancement brand, has introduced new ExtenZe Plus fast acting pills in a five-pack value unit. The new bright red five-pack pills feature an easy-to-take pearlized coating and are being promoted at the same price as the current four-pack unit during introduction through the end of 2010.
Energize profit margins with new Peptime Mini-Whites, a safe and effective caffeine stimulant from DMD Pharmaceuticals that gives users a jump-start when they need it most. Peptime Mini-Whites help restore mental alertness when one is experiencing fatigue or drowsiness. With Peptime Mini-White, users will eliminate their coffee and cola intake and be back at
With healthcare capturing so many headlines these days, the health and beauty category (HBC) has taken on added importance in the c-store set. Fueling much of the growth: smaller package sizes that save shoppers money and stimulate impulse sales. Medford, Ore.-based Minute Market has jumpstarted its HBC sales by mixing in smaller-sized packaging, according to
A U.S. judge has ruled that the U.S. Food and Drug Administration (FDA) does not have the authority to regulate electronic cigarettes, The Wall Street Journal reported. In a 32-page opinion, U.S. District Judge Richard J. Leon sided with electronic cigarette maker Smoking Everywhere Inc., and found that the FDA did not have the authority